Market by Product, Application, Source Type, and Country | Forecast 2021-2028
Triton’s report determines that the Latin American biosurgery market is likely to surge at a CAGR of 7.43% during the predicted period 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries scrutinized in this
market include:
• Brazil
• Mexico
• Rest of Latin America
Factors such as the rising
prevalence of chronic diseases, coupled with the growing geriatric population
prone to orthopedic and neurology disorders, are anticipated to amplify the
demand for biosurgery products across the region over the forecast period.
Other than this, the growing incidence rate of road accidents is expected to
increase the demand for biosurgery products. Hence, these factors are likely to
predominantly contribute to the development of the biosurgery market across
Latin America.
In the region, Brazil is
estimated to witness the highest growth in the biosurgery market over the
forecast period, owing to the rise in chronic diseases and surgeries. For
instance, there is a growing demand for minimally invasive surgery across the
country, influencing the demand for biosurgery products. Other than this, the
growing geriatric population is also supporting the studied market’s growth.
This is mainly because older people tend to be vulnerable to various disorders,
such as orthopedic and neurology disorders, which surges the demand for
biosurgery products. Hence, as stated above, these factors are augmenting the
growth of the biosurgery market within Brazil.
Furthermore, the Mexican
market is likely to progress owing to multiple factors, including the
increasing demand for cosmetic surgeries, growing medical tourism, and the high
occurrence of chronic diseases. Besides, in recent years, there has been a
substantial rise in plastic surgeries. Therefore, these aforementioned factors
are estimated to offer lucrative opportunities to the biosurgery market in
Mexico.
B Braun Melsungen AG is among
the leading suppliers of healthcare products in the field of cardiothoracic
surgery, diabetes care, orthopedic joint replacement, infusion therapy,
neurosurgery, nutrition therapy, pain therapy, and general open surgery, among
others. It offers its products to hospitals, general practitioners, and others.
The company’s product portfolio includes Optilene, a sterile non-absorbable
monofilament surgical suture formed of polypropylene and polyethylene. B Braun
has operations across various regions, including Latin America.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. LATIN
AMERICA BIOSURGERY MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON BIOSURGERY MARKET
2.2. TRENDS
IN BIOSURGERY TECHNOLOGY
2.3. KEY
INSIGHTS
2.4. PORTER’S
FIVE FORCES MODEL
2.4.1. THREAT
OF NEW ENTRANTS
2.4.2. THREAT
OF SUBSTITUTE PRODUCTS
2.4.3. BARGAINING
POWER OF BUYERS
2.4.4. BARGAINING
POWER OF SUPPLIERS
2.4.5. COMPETITIVE
RIVALRY
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. KEY
BUYING OUTLOOK
2.8. KEY
MARKET STRATEGIES
2.8.1. CONTRACTS
AND PARTNERSHIPS
2.8.2. BUSINESS
EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES
2.8.3. ACQUISITIONS
& MERGERS
2.8.4. NEW
PRODUCT LAUNCHES & DEVELOPMENTS
2.9. MARKET
DRIVERS
2.9.1. GROWING
AGING POPULATION
2.9.2. TECHNOLOGICAL
ADVANCEMENTS AND INNOVATIONS IN HEALTHCARE FACILITIES
2.9.3. SURGE
IN SURGICAL TREATMENTS FOR MUSCULOSKELETAL DISORDERS
2.9.4. PREVALENCE
OF SPINAL FUSION AND JOINT RECONSTRUCTION
2.9.5. STRONG
FOCUS ON RESEARCH AND DEVELOPMENT
2.10. MARKET
CHALLENGES
2.10.1. HIGH
COST OF SURGERIES
2.10.2. COMPLICATIONS
RELATED TO IMMUNE RESPONSE
2.10.3. USAGE
OF MINIMALLY INVASIVE SURGERIES
2.11. MARKET
OPPORTUNITIES
2.11.1. RESEARCH
AND INVESTMENTS IN BIOENGINEERING
2.11.2. DEVELOPMENT
OF POLICIES FOR REIMBURSEMENT AND COMPENSATION
3. LATIN
AMERICA BIOSURGERY MARKET – BY PRODUCT
3.1. HEMOSTATIC
AGENTS
3.2. BONE-GRAFT
SUBSTITUTES
3.2.1. SYNTHETIC
GRAFT EXTENDERS
3.2.2. DEMINERALIZED
BONE MATRIX
3.2.3. BONE
MORPHOGENETIC PROTEINS
3.2.4. CELL-BASED
MATRICES
3.3. SURGICAL
SEALING AGENTS
3.3.1. NATURAL
3.3.2. SYNTHETIC
3.4. SOFT-TISSUE
MANAGEMENT
3.4.1. SYNTHETIC
MESH/PATCH
3.4.2. NATURAL
MESH/PATCH
3.5. ANTI-ADHESIVE
AGENTS
3.6. STAPLE
LINE REINFORCEMENT
4. LATIN
AMERICA BIOSURGERY MARKET – BY APPLICATION
4.1. ORTHOPEDIC
SURGERY
4.2. CARDIO
AND THORACIC SURGERY
4.3. NEURO
AND SPINE SURGERY
4.4. GENERAL
SURGERY
4.5. OTHER
APPLICATIONS
5. LATIN
AMERICA BIOSURGERY MARKET – BY SOURCE TYPE
5.1. NATURAL
5.2. SYNTHETIC
6. LATIN
AMERICA BIOSURGERY MARKET – COUNTRY OUTLOOK
6.1. COUNTRY
ANALYSIS
6.1.1. BRAZIL
6.1.2. MEXICO
6.1.3. REST
OF LATIN AMERICA
7. COMPETITIVE
LANDSCAPE
7.1. BAXTER
INTERNATIONAL INC
7.2. BECTON,
DICKINSON AND COMPANY
7.3. B
BRAUN MELSUNGEN AG
7.4. CSL
LIMITED
7.5. ETHICON
INC (JOHNSON & JOHNSON)
7.6. INTEGRA
LIFESCIENCES HOLDINGS CORPORATION
7.7. MEDTRONIC
PLC
7.8. RTI
SURGICAL
7.9. SANOFI
7.10. SMITH
& NEPHEW PLC
7.11. STRYKER
CORPORATION
7.12. WRIGHT
MEDICAL GROUP NV
7.13. ZIMMER
BIOMET HOLDINGS INC
8. RESEARCH
METHODOLOGY & SCOPE
8.1. RESEARCH
SCOPE & DELIVERABLES
8.1.1. OBJECTIVES
OF STUDY
8.1.2. SCOPE
OF STUDY
8.2. SOURCES
OF DATA
8.2.1. PRIMARY
DATA SOURCES
8.2.2. SECONDARY
DATA SOURCES
8.3. RESEARCH
METHODOLOGY
8.3.1. EVALUATION
OF PROPOSED MARKET
8.3.2. IDENTIFICATION
OF DATA SOURCES
8.3.3. ASSESSMENT
OF MARKET DETERMINANTS
8.3.4. DATA
COLLECTION
8.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1: LATIN AMERICA
BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: CONTRACTS AND
PARTNERSHIPS
TABLE 4: BUSINESS EXPANSIONS,
ANNOUNCEMENTS, & DIVESTITURES
TABLE 5: ACQUISITIONS &
MERGERS
TABLE 6: NEW PRODUCT LAUNCHES
& DEVELOPMENTS
TABLE 7: LATIN AMERICA
BIOSURGERY MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA
SURGICAL SEALING AGENTS MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA
SOFT-TISSUE MANAGEMENT MARKET, BY TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: LATIN AMERICA
BIOSURGERY MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 12: LATIN AMERICA
BIOSURGERY MARKET, BY SOURCE TYPE, 2021-2028 (IN $ MILLION)
TABLE 13: LATIN AMERICA
BIOSURGERY MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
FIGURE 1: LATIN AMERICA
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)
FIGURE 2: LATIN AMERICA
BIOSURGERY MARKET, BY PRODUCT, 2020 & 2028 (IN %)
FIGURE 3: LATIN AMERICA
BIOSURGERY MARKET, BY HEMOSTATIC AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA
BIOSURGERY MARKET, BY BONE-GRAFT SUBSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY SYNTHETIC GRAFT EXTENDERS, 2021-2028 (IN $
MILLION)
FIGURE 6: LATIN AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY DEMINERALIZED BONE MATRIX, 2021-2028 (IN $
MILLION)
FIGURE 7: LATIN AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY BONE MORPHOGENETIC PROTEINS, 2021-2028 (IN $
MILLION)
FIGURE 8: LATIN AMERICA
BONE-GRAFT SUBSTITUTES MARKET, BY CELL-BASED MATRICES, 2021-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA
BIOSURGERY MARKET, BY SURGICAL SEALING AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA SURGICAL
SEALING AGENTS MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA SURGICAL
SEALING AGENTS MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA BIOSURGERY
MARKET, BY SOFT-TISSUE MANAGEMENT, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA
SOFT-TISSUE MANAGEMENT MARKET, BY SYNTHETIC MESH/PATCH, 2021-2028 (IN $
MILLION)
FIGURE 14: LATIN AMERICA
SOFT-TISSUE MANAGEMENT MARKET, BY NATURAL MESH/PATCH, 2021-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA BIOSURGERY
MARKET, BY ANTI-ADHESIVE AGENTS, 2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA BIOSURGERY
MARKET, BY STAPLE LINE REINFORCEMENT, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA BIOSURGERY
MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 18: LATIN AMERICA BIOSURGERY
MARKET, BY ORTHOPEDIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA BIOSURGERY
MARKET, BY CARDIO AND THORACIC SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA BIOSURGERY
MARKET, BY NEURO AND SPINE SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA BIOSURGERY
MARKET, BY GENERAL SURGERY, 2021-2028 (IN $ MILLION)
FIGURE 22: LATIN AMERICA BIOSURGERY
MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 23: LATIN AMERICA BIOSURGERY
MARKET, BY SOURCE TYPE, 2020 & 2028 (IN%)
FIGURE 24: LATIN AMERICA BIOSURGERY
MARKET, BY NATURAL, 2021-2028 (IN $ MILLION)
FIGURE 25: LATIN AMERICA BIOSURGERY
MARKET, BY SYNTHETIC, 2021-2028 (IN $ MILLION)
FIGURE 26: BRAZIL BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 27: MEXICO BIOSURGERY MARKET
2021-2028 (IN $ MILLION)
FIGURE 28: REST OF LATIN AMERICA
BIOSURGERY MARKET 2021-2028 (IN $ MILLION)